Evidence map›Paper›PMID 35838981›Full record

ArticleCanadian journal of public health = Revue canadienne de sante publique2022

Drivers of medicalization in the Canadian Adult Obesity Clinical Practice Guidelines.

Andrea E Bombak, Louise Adams, Patricia Thille

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Canadian journal of public health = Revue canadienne de sante publique, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Ozempic and Wegovy Meet Congress: Political Economy Without Critique and Sociology Without Society.International journal of social determinants of health and health services · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Andrea E BombakDepartment of Sociology, University of New Brunswick, 3 Bailey Drive, P.O. Box 4400, Fredericton, New Brunswick, E3B 5A3, Canada. abombak@unb.ca.ORCID 0000-0002-4235-9025
Louise AdamsFlourish Kirribilli, 13/1 Broughton St, Kirribilli, NSW, 2061, Australia.ORCID 0000-0002-4744-7518
Patricia ThilleDepartment of Physical Therapy, College of Rehabilitation Sciences, University of Manitoba, Room R131 - 771 McDermot Ave., Winnipeg, MB, R3E 0T6, Canada.ORCID 0000-0003-1961-9818

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The new Canadian Adult Obesity Clinical Practice Guidelines frame higher body weight as a chronic, relapsing disease requiring comprehensive medical treatment pathways. In this commentary, we will demonstrate how a process called pharmaceuticalization is informing the new guidelines. We join those questioning the normalization of industry and medical collaboration and interrogate whether the new guidelines meaningfully address stigma.

Indexed as

MedicalizationSocial StigmaAdultCanadaHumansObesityConflict of interestDrug industryMedicalizationPractice guidelines as topicWeight prejudice

Identifiers

PMID35838981
PMCPMC9481752

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.